AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

INNODIA Family & Friends Early-Stage T1D Detection Protocol

Recruitingn/aAges 1 Year - 45 YearsAllINNODIA iVZW
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The purpose of INNODIA DETECT is to identify people who are at increased risk of developing T1D. Investigators are doing this by testing for markers in the blood (autoantibodies) that tell them an individuals risk of getting T1D in the future. What is Type 1 Diabetes (T1D)? T1D is a serious disease where the blood glucose (sugar) level is too high because the body cannot make a hormone called insulin. This happens when the body's immune system attacks the cells in the pancreas that make insulin (called beta cells), meaning that insulin production stops. This is harmful to the body as insulin does an essential job. It allows the glucose in the blood to enter cells and fuel the body, resulting in a lowering of the blood glucose level. What are Autoantibodies? T1D autoantibodies are markers found in the blood that indicate that the destruction of insulin producing cells has begun. The r

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Have given written informed consent to participate 2. Be aged between 1 and 45 years 3. Have a family relative with T1D or close friend diagnosed with symptomatic T1D at age \<45 years Exclusion Criteria: 1. Previous diagnosis of stage 3 T1D or other forms of diabetes 2. Unable/unwilling to consent to participation
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

21 sites
Medical University of Vienna
Vienna, Austria
Katholieke Universiteit Leuven
Leuven, Belgium
Motol University Hospital
Prague, Czechia
Angers University Hospital Center (CHU Angers)
Angers, France
Avicenne Hospital
Bobigny, France
Jean Verdier Hospital
Bondy, France
Centre Hospitalier Sud Francilien (CHSF)
Corbeil-Essonnes, France
DIAB-eCARE Hospices Civils de Lyon
Lyon, France

โ€ฆand 13 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy